The BXSB murine model of systemic lupus erythematosus is differentiated from other murine models of lupus by a severe monocytosis. The recently identified Y-linked autoimmune accelerator locus, Yaa, which is fundamental to accelerated disease in male BXSB mice, is required for the monocytic phenotype in BXSB. It has also recently been shown to induce monocytosis in combination with the Nba2 locus from NZB. To dissect the genetic basis and associated pathogenicity of BXSB-related monocytosis, a panel of existing congenic mice were studied and a novel sub-congenic mouse B10.Y BXSB .BXSB-Bxs3 was generated. Monocytosis was found to be caused by an epistatic interaction between Yaa and the telomeric region of chromosome 1, an area of approximately 30 cM. Bxs3 and Yaa together were sufficient to generate monocytosis equivalent to that of BXSB. In contrast to the NZB model, however, where monocytosis tightly correlated with autoantibody production and lethal lupus nephritis, this was not the case in BXSB. While Yaa þ mice bearing the Bxs3 locus drive monocytosis, glomerulonephritis and autoantibody production, both autoantibody production and nephritis are discreet events that occur in the absence of the Bxs3 locus. Yaa is a pre-requisite for monocytosis, demonstrating a novel synergistic interaction between Yaa and Bxs3.
Introduction
The recombinant strain, BXSB, represents an excellent model of SLE. BXSB mice spontaneously develop an autoimmune disease characterized by the production of a wide range of autoantibodies to nuclear components. Disease phenotype is manifested in proliferative glomerulonephritis, splenomegaly, lymphadenopathy and monocytosis. Other recombinant strains, for example NZB and MRL, display strikingly similar characteristics, excluding the monocytic phenotype.
The Y chromosome-linked autoimmune accelerator locus Yaa, recently identified as a TLR7 gene duplication, 1, 2 accelerates disease in male BXSB mice, and can accelerate disease in NZB when F1 hybrids are generated. In addition to the accelerated onset of autoimmune pathology, the presence of Yaa in these recombinant strains also results in monocytosis. 3 Furthermore, it has recently been demonstrated that while Yaa is not sufficient to cause manifestation of full autoimmune pathology in non-autoimmune prone mice, for example C57BL/6, it is sufficient to break tolerance and can drive low-level anti-chromatin autoantibody production and antinuclear antibodies (ANA) in C57BL/10. 4 That monocytosis in BXSB is a combined effect between Yaa and other BXSB loci is further illustrated by the BXSB/longlived (BXSB/ll) strain, which demonstrates a significant delay in the expression of autoimmune pathology, including delayed onset of monocytosis, 5 even though this strain has recently been shown to carry the Yaa locus. 6 BXSB-related monocytosis was first reported by Wofsy et al. 7 when a dramatic progressive increase in monocytes was detected from as early as 2 months in the peripheral blood. By 6 months, 50-90% of the peripheral blood was monocytic. No effect was seen in female mice. Subsequently, Vieten and Muller reported a higher number of monocyte colony-forming units (CFU-M) in the bone marrow of male BXSB compared to female littermates and controls. Up to seven times more CFU-M were detected at 12 weeks of age, with this elevated number of bone marrow myeloid precursor cells increasing during their lifetime in parallel with the observed peripheral monocytosis. 8 Comparable results were not detected in either SB/Le or NZB/W, although high levels of macrophage colony-stimulating factor (M-CSF) were detected in the plasma of three autoimmune strains BXSB, NZB/W and MRL/lpr/lpr. 9 Following allogeneic bone marrow transplantation of male BXSB mice, Ikehara et al. 10 reported an amelioration of nephritis and a return to the normal number of peripheral monocytes in the blood. While these three studies clearly identify differences in bone marrow precursor populations in BXSB male mice, the causative effect is still unclear. Recent studies, using Yaa plus non-Yaa mixed bone marrow chimaeras, have reported that Yaa-related monocytosis is not due to an intrinsic growth abnormality of monocytes from Yaa-bearing mice. 11 The same group has recently reported a correlation of monocytosis with autoantibody production and the subsequent development of lethal nephritis in B6 Â (NZB Â B6.Yaa) F1 male mice. 3 In this model, monocytosis was found to be linked to Nba2, an NZB-derived locus on chromosome 1, the same region shown to be involved in monocytosis (Sle1a/b) in an earlier study on NZM2410-derived congenic mice. 12 Furthermore, it was postulated that the low-level expression of the NZB-type Fcgr2b allele, which encodes the inhibitory FcgRIIB and lies within the Nba2 locus, may contribute to the monocytic phenotype by preferentially activating effector cells via the stimulatory FcgR receptor.
The polygenic nature of SLE is well documented. We have previously reported the generation of congenic mice for BXSB chromosome 1, and demonstrated that separate intervals direct different aspects of disease. 4 In an attempt to further define the BXSB and Yaa-related monocytosis, an extensive analysis of peripheral, tissuespecific and bone marrow-derived monocytes in our different congenic lines and a novel sub-congenic line, B10.Yaa.Bxs3, was performed. Mice were studied over a period of 12 months to establish the onset and progression of monocytosis and the associated autoimmune pathology.
Results
Monocytosis in B10.Yaa.Bxs2/3 congenic mice requires the presence of both Yaa and the telomeric region of chromosome 1 To investigate the levels of monocytic cells in BXSB congenic mice, absolute numbers of CD11b þ expressing splenocytes were determined across a 12-month time course at two monthly intervals. The CD11b þ monocyte population was found to be slightly elevated in all Yaa þ mice compared to B10 control mice (Figure 1 ), however, this was significant only in B10.Yaa.Bxs2/3 and BXSB mice from 4 months of age onwards (Pp0.001) from B10 and B10.Yaa. Both strains demonstrated similar monocytic profiles until 8 months of age at which time point BXSB were no longer observed due to high mortality. By 12 months of age, B10.Yaa.Bxs2/3, which demonstrate prolonged survival times compared to parental BXSB, 4 revealed a 17-fold higher population of monocytes than B10 (Pp0.001) and an eightfold higher population than B10.Yaa (Pp0.001). B10.Yaa.Bxs1/4 and B10.Yaa.Bxs1/2 showed similar profiles to B10.Yaa. CD14 demonstrated very similar staining profiles, confirming the elevated population to be monocytes (Supplementary Figure 7) . The monocytes were negative for expression of CD62L (data not shown). There was no concomitant increase in the proportion of macrophages as determined by F4/80 staining or neutrophils as revealed by NK1.1 staining, respectively (data not shown).
Generation and phenotyping of a mouse strain congenic for the BXSB lupus-susceptibility loci Bxs3 To facilitate a more detailed analysis of the role played by genes located in the telomeric region of chromosome 1 in susceptibility to monocytosis, a sub-congenic line was generated using a speed congenic approach 13 and used for comparative analyses with B10.Yaa.Bxs2/3. A panel of 11 microsatellite markers was used to select offspring from a (B10 Â B10.Yaa.Bxs2/3)F 2 . The congenic mice generated were named after the BXSB susceptibility locus they contained 4 Figure 2a .
Significant mortality (log-rank test) was observed for B10.Bxs3 mice (Figure 2b ), which had 25% mortality by 12 months (Pp0.01) from B10 and B10.Yaa. Mortality was significantly less (Pp0.05) than that observed in B10.Yaa.Bxs2/3, which had 50% mortality by 12 months. Histological studies of B10.Yaa.Bxs3 revealed an agedependent glomerulonephritis that was both qualitatively and quantitatively similar to B10.Yaa.Bxs2/3, but with delayed onset (data not shown).
B10.Yaa.Bxs3 developed an elevated production of ANA compared to B10 and B10.Yaa (Figure 2c ). Production was significantly higher in B10.Yaa.Bxs2/3 than B10.Yaa.Bxs3 until 6 months of age (Pp0.01) at which point ANA titres in the two congenic strains became equivalent. Age of onset of ANA production was therefore younger in B10.Yaa.Bxs2/3, but comparable levels were achieved in the two congenics by 12 months. Similar patterns were obtained for titres of ssDNA and dsDNA autoantibodies-delayed onset of production, but equivalent titres by 12 months (data not shown).
Monocytosis detected in the spleen, blood and bone marrow of Yaa þ mice containing the telomeric region of chromosome 1 Following the generation of a Yaa þ congenic line containing only the telomeric region of chromosome 1 (B10.Yaa.Bxs3), a comparative analysis was performed of the percentage of CD11b þ cells in the spleen, blood and bone marrow of parental and congenic mice at 3 and 10 months of age. Monocytosis was most apparent in the spleen ( Figure 3) , with elevated levels in all Yaa þ mice compared to B10 (Pp0.01). Significant splenic monocytosis was observed in BXSB, B10.Yaa.Bxs2/3 and B10.Yaa.Bxs3, with percentage populations of 48, 54 and 51%, respectively, compared to 29% (B10) and 38% (B10.Yaa) at 3 months of age. No significant differences were detected between the three monocytic strains. Female B10.Bxs3 carrying the telomeric region of chromosome 1, but not Yaa, demonstrated a similar profile to B10, and thus a significantly lower percentage of monocytes compared to their male littermates. Monocytosis was also observed in the blood and bone marrow of BXSB, B10.Yaa.Bxs2/3 and B10.Yaa.Bxs3. Once again there was no significant difference between the monocytic strains. In all monocytic strains, at least twice as many CD11b þ cells were found in the spleen than in the blood, and threefold more than in the bone marrow. Results obtained were similar for CD14 (data not shown). By 10 months of age (Figure 2b) , monocytosis was significantly elevated in BXSB, B10.Yaa.Bxs2/3 and B10.Yaa.Bxs3, with percentage populations of 77, 82 and 88%, respectively, compared to 33% (B10), 46% (B10.Yaa) and 30% (female B10.Bxs3).
Further phenotypic analysis of B10.Yaa.Bxs2/3, B10.Yaa.Bxs3 and control BXSB and B10.Yaa splenocytes (Figure 4 ) confirmed the differences in the myeloid population to be specifically restricted to monocytes. No differences were detected in the populations of macrophages (Table 1) Immunohistochemical analyses of 2 months splenic tissue sections confirmed the flow cytometric data, demonstrating diffuse populations of monocytes throughout the splenic tissue in B10.Yaa.Bxs2/3, B10.Yaa.Bxs3 and BXSB mice ( Figure 5 ). CD11b þ cells (M) are interspersed between the enlarged B-cell follicles as revealed by B-cell staining with anti-CD45R antibody (Supplementary Figure 8) . The elevated level of MHC class II expression detected by flow cytometry, discussed above (Table 1) , is also apparent in the monocytic strains (Supplementary Figure 8) observed by immunohistochemistry. Limited background staining was detected with the isotype controls ( Figure 5) . Similarly, although slightly more intense, CD11b staining patterns were detected at 6 months of age, with large numbers of monocytes detected between greatly enlarged B-cell follicles (data not shown).
Differential responsiveness to M-CSF by B10.Yaa.Bxs3 congenic mice To further define the monocytosis linked to the telomeric region of chromosome 1, colony formation studies were performed using bone marrow-derived populations in an in vitro culture system. The total yield of cells obtained following 7 days culture in the presence of recombinant M-CSF was significantly higher in the previously identified monocytic mice compared to both B10 (Pp0.01) and B10.Yaa (Pp0.05) as represented in Figure 6a . Total cell yields from B10.Yaa mice were again enhanced compared to B10 alone, although to a significantly lower level than that observed for B10.Yaa.Bxs2/3, B10.Yaa.Bxs3 and BXSB. Highest cell yields were obtained from B10.Yaa.Bxs3, which produced three times more monocytes than B10.Yaa and six times more than B10. No significant differences were detected between the monocytic strains themselves. If the number and size of CFU, rather than the total cell yield, was measured, a clear difference became apparent between B10.Yaa.Bxs3 and the remaining two strains B10.Yaa.Bxs2/3 and BXSB (Figure 6b ). B10.Yaa.Bxs3 demonstrated significantly higher numbers of larger CFU (450 cells per CFU) (Pp0.01 compared to both BXSB and B10.Yaa.Bxs2/3) and fewer smaller CFU. The overall total number of CFU was remarkably similar between the three strains and more than fourfold higher than that of B10 and B10.Yaa cultures. Of note, while the overall number of CFU was not significantly different between B10 and B10.Yaa, B10.Yaa produced a greater number of larger CFU than did B10.
At reduced concentrations of recombinant M-CSF, while a trend towards higher cell yields were apparent in B10.Yaa and B10.Yaa.Bxs3 strains compared to B10, this was not significantly different, suggesting no difference in sensitivity to the growth factor as reported previously. 9 Interestingly, at higher concentrations, significantly more cells were produced by both B10.Yaa (Pp0.05) and B10.Yaa.Bxs3 (Pp0.01), with B10.Yaa.Bxs3 producing three and six times more cells than B10.Yaa and B10, respectively, at a concentration of 50 ng ml 
Discussion
It has previously been demonstrated that BXSB develop an age-related monocytosis compared to female littermates and to control non-autoimmune strains. 5, [7] [8] [9] 11, 14 Yaa is a known disease accelerating factor in the BXSB model, and is also capable of driving monocytosis in NZB when F1 hybrids are generated.
3,15
The results presented here demonstrate that while monocyte levels were slightly elevated in the peripheral blood of all Yaa þ mice from 2 months of age onwards, levels were increased significantly in B10.Yaa.Bxs2/3, localizing susceptibility to monocytosis to the Bxs2/3 loci (Figure 1 ). These data are in agreement with recently published data by Kikuchi et al. 3 who used a B6 Â (NZB Â B6.Yaa) backcross model to correlate monocytosis with the NBA-derived locus Nba2. The fact that Bxs3 on a Yaa background was capable of driving monocytosis in the absence of Bxs2 was confirmed by the significantly elevated percentages of CD11b þ mononuclear cells in the peripheral blood, spleen and bone marrow tissue of the newly generated sub-congenic strain B10.Yaa.Bxs3 (Figure 3) .
Compared to B10 control, no significant increase in monocyte numbers in any of the three organs was detected in female B10.Bxs3 by 10 months of age, indicating that the presence of Bxs3 alone is not enough to drive monocytosis. In contrast, significant monocytosis was detected at this time point in both the peripheral blood and splenic tissue of mice carrying only the Yaa locus, but the monocytosis was at a significantly lower level than that measured in either B10.Yaa.Bxs2/3 or B10.Yaa.Bxs3 congenic strains. Yaa has recently been identified as a translocation/duplication of the TLR7 locus in the pseudoautosomal region of the Y chromosome.
1,2 TLR7 is one of the four nucleic acid sensing Toll receptors, specifically recognizing ssRNA. Triggering of TLR7 is known to stimulate the production of large amounts of pro-inflammatory cytokines, including interferon-a, which has been shown to enhance antigen presentation capacity of both B cells and DCs driving T cell development and activation as well as B cell hyperresponsiveness and increased deposition of immune complexes in the glomeruli. 1 Furthermore, ligation of TLR7 has previously been implicated in the activation of monocytes isolated from MRL.lpr mice, 16 but its direct role in monocytosis is unknown. However, it is clear from these data that it affects monocyte levels. To conclude, in the presence of Yaa alone, we see significant low-level monocytosis (37% in B10.Yaa versus 29% in B10), but with the additional presence of Bxs3, the level of monocytosis further increases to 450% (B10.Yaa.Bxs2/ 3 and B10.Yaa.Bxs3). The level of monocytes produced by mice carrying Yaa and Bxs3 together is comparable to that of BXSB, and thus no other Bxs loci are necessary to drive the monocytic phenotype.
The rise in CD11b þ cells in congenic mice containing the Bxs2 and Bxs3 loci was not solely a reflection of an increase in all mononuclear cells in these strains, as the number of macrophages (F4/80 þ ) remained constant ( Table 1 ). The 8% increase in the population of B lymphocytes in B10.Yaa.Bxs3 compared to B10.Yaa control mice, was comparable with the published data for B10.Yaa.Bxs2/3. 4 The fact that the monocytes were negative for expression of CD62L (data not shown) is suggestive of the fact that they derive from the previously reported resident population of monocytes rather than the inflammatory subset. 11 The increased numbers of MHC class II expressing cells reflects the increased population of B lymphocytes. Thus, overall, the immune phenotype of B10.Yaa.Bxs3 does not differ significantly from that of parental B10.Yaa.Bxs2/3. Monocytosis is clearly visible in the splenic tissue ( Figure 5 ) where germinal centres and follicles are surrounded by the dramatically increased monocyte population. Bxs3 lies in the telomeric region of chromosome 1 that contains the previously identified lupus susceptibility genes Fcgr2 and Ifi202, which encode inhibitory FcgRIIB [17] [18] [19] and interferon-inducible 202, 20 respectively. The presence of monocyte-driving genes in Bxs3, therefore, supports the linkage analyses of Croker et al. 12 who mapped monocytosis to the Sle1a/b interval and Kikuchi et al., 3 mapping monocytosis to a peak coincident with Fcgr2b. We have confirmed that the Fcgr2 gene present in B10.Yaa.Bxs3 derives from the BXSB parental strain (data not shown). This is the same variant as is present in NZB, however, the NZM2410 mouse model has the NZW variant at this position, which differs from the NZB variant in expression level, 19 although it carries the same protein haplotype. 21 This may rule out Fcgr2b as the candidate monocytosis gene. However, Ifi202 is also overexpressed in Bxs2/3 mice 22 and the signalling lymphocyte activation molecule (SLAM) locus is the same haplotype as NZB 23 (unpublished NJ Rogers, SJ Rose and BJ Morley), all of which are strong candidates.
One unique factor of B10.Yaa.Bxs3 compared to B10.Yaa.Bxs2/3 was the size of CFU generated during in vitro culture (Figure 6 ). No significant difference was detected in overall monocyte number, but the size and frequency of the CFU was significantly different (fewer, larger, colonies). No difference was detected in the susceptibility of the congenic mice to low level concentrations of M-CSF compared to each other, or to parental controls, as previously reported by Vieten et al. 9 In contrast, at higher M-CSF concentrations, more cells were produced by both B10.Yaa and B10.Yaa.Bxs3, suggesting an ability to produce higher cell numbers when the growth factors are not limiting. These data cannot easily be explained in terms of M-CSF or granulocyte-macrophage-CSF production, as neither growth factor maps to chromosome 1, nor do their respective receptors (Ensembl mouse genome assembly National Centre for Biotechnology Information 39 (http://www.ensembl.org/Mus_musculus/). We can thus exclude a direct role for increased expression of granulocyte-macrophage-CSF or M-CSF as the causative agents of monocytosis in the Bxs3 locus. In contrast to Kikuchi et al., 3 our data do not demonstrate exclusive linkage of monocytosis with autoantibody production and nephritis. Combining our previous data, 4 with the data reported here, we can conclude that while Bxs3 drives monocytosis, glomerulonephritis, and autoantibody production, both autoantibody production and nephritis are discreet events that can occur in the absence of each other and also in the absence of Bxs3. Bxs1 promotes nephritis in the absence of high titre autoantibody or monocytosis, Bxs2 drives anti-dsDNA autoantibody production in the absence of nephritis and monocytosis, and Bxs4 directs an increase in titre of autoantibodies in the absence of monocytosis. 4 In summary, these data demonstrate a novel synergistic interaction between Yaa and Bxs3, which drives monocytosis in BXSB sub-congenic mice. Furthermore, the sub-congenic approach has revealed that monocytosis in the BXSB strain is not necessarily a pre-requisite for elevated autoantibody production and onset of nephritis as was previously demonstrated for the NZB F1 model, once again underlying the differences between these lupus models and increasing the importance of studying both in developing a complete picture of lupus aetiology.
Materials and methods

Mice
Mice were bred and maintained under identical conditions at Imperial College from original stocks: BXSB from the Jackson Laboratory (Bar Harbor, ME, USA) and B10 from Harlan Olac Ltd (Bicester, UK). Both lines have now been maintained for more than 20 generations with no change in serological characteristics or mortality. (B10 Â B10.Yaa.Bxs2/3)F 2 offspring were selected using 11 microsatellite markers in a speed congenic approach. 13 Lines were fixed by brother-sister mating after six backcrosses. All congenic mice analysed were male, consomic for the Y chromosome from BXSB and therefore Yaa þ , and free from disease pathogens. The B10.Yaa.Bxs2/3 congenics have been published previously. 4 Age-matched B10, B10-Y BXSB (B10.Yaa) and BXSB mice were included as controls for all analyses. For immunohistochemistry, the primary antibodies used to detect cell surface receptors were as follows: rat anti-CD45R (anti-B cells, IgG2a, BD), rat anti-CD11b (anti-monocytes, IgG2b), rat anti-I-Ab (anti-MHC class II, IgG2a), rat anti-CD14 (anti-monocytes, IgG1) in combination with the appropriate isotype-matched controls. All purchased from Caltag unless otherwise stated. These were all used at an optimal concentration of 5 mg ml À1 . Pre-absorbed horseradish peroxidase-conjugated rabbit anti-rat Ig (1/100, Sigma) was used as the detection antibody.
Antibodies and reagents
Serological analyses
A total of 32 mice for each strain were bled and analysed at two monthly intervals from 2 months of age until killing at 12 months. BXSB mice were tested at 1-month intervals from 2 to 8 months of age. ANA levels were measured by indirect immunofluorescence using Hep-2 cells and an FITC-conjugated IgG Fc-specific anti-mouse Ab. Samples were screened at a 1/40 dilution and positive samples were titrated to end point.
Cohorts of mice were compared using Mann-Whitney U test or one-way analysis of variance with GraphPad Prism Software (San Diego, CA, USA). Mortality data were assessed using a log-rank w 2 test with 1 d.f. A cohort of 45 mice was observed over the 12-month period.
Autopsy analysis
A cohort of eight mice was killed every 2 months from 2 months of age until 10 months. The mice that had been serially bled were killed at 12 months. After killing, the spleen was removed and weighed. Kidneys were removed and fixed in formal saline before staining with haematoxylin and eosin for histopathological analysis of glomerulonephritis as described previously. 4 Coded kidney sections were scored with respect to the intensity and extent of mesangial matrix increase and glomerular hypercellularity. Samples were graded on a scale 0-4, where 0 signified no histological changes, 1 indicated o25% abnormal glomeruli, 2 corresponded to 25-50%, grade 3 was 51-75% and 4 indicated 475%. Grades 2-4 were considered positive for glomerulonephritis, grade 0 was negative.
Preparation harvesting and culture of bone marrow cells Mice were killed by cervical dislocation and the femurs were removed. Bone marrow was eluted aseptically by perfusion of the femur with Dulbecco's modified Eagle's medium using a 23-gauge sterile needle and a 10-ml syringe. Tituration using the needle ensured a single cell suspension was obtained. After centrifugation, the cells were plated out in 35 mm Petri dishes at 1 Â 10 5 cells ml À1 in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 100 IU ml À1 penicillin, 2 mM L-glutamine and 100 mg ml À1 streptomycin and 25 ng ml À1 recombinant M-CSF (R&D Systems, Oxfordshire, UK). Bone marrow cells were cultured at 371C for 7 days. Fresh medium containing 25 ng ml À1 recombinant M-CSF was provided on days 3 and 5. Cells were harvested using a 21-gauge sterile needle and were maintained on ice until use.
CFU enumeration
After 7 days in vitro culture with recombinant M-CSF, the number and size of CFU were determined prior to cell harvesting. CFU were scored as small (o50 cells per CFU) or large (450 cells per CFU) and the total number determined. Five fields of 0.5 cm 2 were observed per plate for 10 replicate plates and the total count per well was determined.
Immunohistochemical analysis
Freshly removed spleens were embedded in OCT compound (VWR, Leicestershire, England) in freezing cassettes (VWR). The embedded tissues were then snap frozen in liquid nitrogen and stored at À801C. To examine the presence and distribution of monocytes, macrophages and B cells within the tissues, snap-frozen spleens were cryosectioned and fixed for 20 min with icecold acetone. The tissues were then incubated with the appropriate primary antibody: CD11b, I-A b ; CD14; CD45R or isotype control, for 60 min in a humidified chamber. Sections were washed four times with phosphate-buffered saline prior to the addition of polyclonal anti-rat Ig-horseradish peroxidase. After washing and development with Sigma Fast 3,3 0 Diaminobenzidine, the slides were counterstained with Harris Haemotoxilin (Fisher Scientifics, Loughborough, UK) to reveal tissue structure and subsequently mounted in Kaiser's solution.
Preparation of splenocytes and peripheral blood samples Mice were serially bled through the tail vein and samples harvested into heparin. Cells, excluding erythrocytes, were counted and stained at 2.5 Â 10 5 per tube. Erythrocytes were removed at the end of the staining procedure following fixation in fluorescence-activated cell sorter lysis buffer.
Spleens from parental and congenic mice were harvested. Single-cell suspensions were prepared in 15 ml serum-free RPMI medium by mashing the spleens through a 70 mm sieve. The cells were centrifuged at 1800 r.p.m. for 5 min. The erythrocytes were lysed by incubation in ammonium chloride lysis buffer (15 mM NH 4 Cl, 10 mM NaHCO 3 , 1 mM EDTA pH 7.4). The cells were washed again by centrifugation and resuspended in 10 ml of RPMI containing 10% fetal calf serum.
Flow cytometric analysis
To examine the expression of surface antigens, cells (2 Â 10 5 ) were incubated with the appropriate directly conjugated antibody for 30 min on ice. Cells were washed twice with ice-cold fluorescence-activated cell sorter buffer (phosphate-buffered saline, 1% fetal calf serum, 0.05% sodium azide) and fixed with fluorescenceactivated cell sorter lysis solution (Sigma). Cells were subsequently analysed on FACScalibur flow cytometer (Becton Dickinson) using CellQuest software. Forward and side scatter gating excluded dead cells and 10 000 events were counted per sample.
